1 Dividend Powerhouse Retirees Can Lean On Even If Rates Hike

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • Smoke-free products now drive 43% of Philip Morris's net revenues, backing 17 consecutive dividend hikes, including an 8.9% raise in 2025.

  • PM's trailing payout ratio sits at 78%, but 2026 free cash flow near $12 billion comfortably covers the $9 billion annual dividend.

  • Nine directors bought PM shares at $169.93 on May 6, and with no buybacks planned through 2026, the dividend claims first call on cash.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Philip Morris International didn't make the cut. Grab the names FREE today.

1 Dividend Powerhouse Retirees Can Lean On Even If Rates Hike

© brizmaker / Shutterstock.com

Philip Morris International (NYSE:PM | PM Price Prediction) is a tobacco giant in the middle of a profitable pivot, with smoke-free products now accounting for over 43% of net revenues through IQOS heat-not-burn devices and ZYN nicotine pouches. With markets nervous about a potentially hawkish Federal Reserve under Kevin Warsh, retirees want to know if this 3% yielder can keep delivering. I dug into the payout math to find out.

Dividend Snapshot

Metric Value
Annual Dividend $5.88 per share
Dividend Yield 3.13%
Consecutive Years of Increases 17 years
Most Recent Increase 8.9% (September 2025)
Dividend Aristocrat Status No (since 2008 spin-off)

Payout Ratios Are Elevated but Covered by Smoke-Free Cash

PM paid roughly $9.1 billion in dividends against $12.233 billion of operating cash flow in FY2025. On 2026 guidance for $13.5 billion in OCF and $1.4 to $1.6 billion of capex, free cash flow should land near $12 billion, comfortably above the payout.

Metric TTM Value Assessment
Earnings Payout Ratio (FY25 EPS $7.54) ~78% Elevated
Forward Payout (2026 guide $8.36 to $8.51) ~70% Improving
FCF Payout Ratio ~76% Healthy
Operating Cash Flow Coverage 1.34x Adequate

Negative Equity Looks Scary, but Leverage Is on the Way Down

The Swedish Match acquisition left shareholders’ equity at negative $7.3 billion, making debt-to-equity less informative here. Leverage is the key metric: management is targeting net debt to adjusted EBITDA near 2.0x by year-end 2026, supported by $5.45 billion in cash and EBITDA of $18.6 billion. Interest coverage remains comfortable given FY2025 operating income of $14.892 billion.

17 Straight Hikes and No Buybacks Competing for Cash

Year Annual Dividend
2026 (run-rate) $5.88
2025 $5.64
2024 $5.20
2023 $5.14
2021 $4.90

PM has raised every year since spinning off in 2008, and importantly, no share repurchases are planned in 2025 or 2026. The dividend gets first call on cash.

Management Calls It a Progressive Dividend Policy

On the Q1 2026 call, CEO Jacek Olczak stated, “We remain firmly committed to our progressive dividend policy and to returning value to shareholders as our transformation delivers sustainable long-term growth.” CFO Emmanuel added that the business is “supported by remarkable cash generation and a strong balance sheet.” Nine directors also bought stock at $169.93 on May 6, 2026.

The Verdict: Safe, With Smoke-Free Doing the Heavy Lifting

Dividend Safety Rating: Safe. The payout ratio is elevated near 78% on trailing earnings, but 2026 guidance of 10.9% to 12.9% EPS growth rapidly relieves that pressure, and FCF coverage is solid. The income case holds if IQOS and ZYN keep compounding at current rates and management hits the 2.0x leverage target. I would grow cautious if combustible volume declines accelerate beyond the guided 3% or FDA action restricts ZYN. For now, the cigarette dividend is still lit.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

KMX Vol: 7,330,419
GLW Vol: 22,800,969
INTC Vol: 233,719,006
SMCI Vol: 68,465,534
ENPH Vol: 13,978,376

Top Losing Stocks

ACN Vol: 41,744,333
EPAM Vol: 5,636,587
CTSH Vol: 61,311,400
CTRA Vol: 73,319,495
KR Vol: 26,704,230